SEC Comment Letter 0000000000-25-001502 to BRIGHT MINDS BIOSCIENCES INC. (DRUG)
BRIGHT MINDS BIOSCIENCES INC.
Date: Feb. 11, 2025 · CIK: 0001827401 · Accession: 0000000000-25-001502
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284694
Letter
February 11, 2025 Ian McDonald Chief Executive Officer Bright Minds Biosciences Inc. 19 Vestry Street New York, NY 10013 Re:Bright Minds Biosciences Inc. Registration Statement on Form F-3 Filed February 5, 2025 File No. 333-284694 Dear Ian McDonald: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Michael Shannon, Esq.
Show Raw Text
February 11, 2025
Ian McDonald
Chief Executive Officer
Bright Minds Biosciences Inc.
19 Vestry Street
New York, NY 10013
Re:Bright Minds Biosciences Inc.
Registration Statement on Form F-3
Filed February 5, 2025
File No. 333-284694
Dear Ian McDonald:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Michael Shannon, Esq.